Exploring targeted therapies against RFPL3 for non-small cell lung cancer with lymph node metastasis
This study revealed the critical role of RFPL3 in NSCLC, suggesting that RFPL3 might serve as both a biomarker and a therapeutic target for this type of cancer, which provides new insight for improving patient prognoses.
Authors
- Chuan Lin (ORCID: https://orcid.org/0000-0002-3607-4509)
- Fei Xu (ORCID: https://orcid.org/0000-0002-5572-5338)
- Yi Jiang (ORCID: https://orcid.org/0000-0001-8402-658X)
Institutions
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Provincial Cancer Hospital (CN)
- Jiangxi Chest Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1007/s12672-025-04116-4
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00